Use of intravenous lidocaine to prevent reperfusion injury and subsequent multiple organ dysfunction syndrome

Journal of Veterinary Emergency and Critical Care

Volumn 13, Issue 3, 2003, Pages 137-148

  Cassutto, Benjamin H ^a   Gfeller, Roger W ^b  

^a Lightbeacon Veterinary Services   (United States)

^b Veterinary Emergency Service   (United States)

Author keywords

Inflammation; Local anesthetics; Oxygen radicals; Trauma

Indexed keywords

EID: 27744587697     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1046/j.1435-6935.2003.00080.x     Document Type: Review

References (68)

1. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia–reperfusion injury. Anesthesiology 2001; 94: 1133 – 1138.pmid/11465607
2. Rochat MC. An introduction to reperfusion injury. Compend Contin Educ Pract Vet 1991; 13 (6): 923 – 930.
3. Yamazaki S, Fujibayashi Y, Rajagopalan RE, et al. Effects of staged versus sudden reperfusion after acute coronary artery occlusion in the dog. J Am Coll Cardiol 1986; 7: 564 – 572.pmid/3950236
4. Winquist RJ, Kerr S. Cerebral ischemia–reperfusion injury and adhesion. Neurology 1997; 49: S23 – S26.pmid/9371145
5. Kong SE, Blennerhassett LR, Heel KA, et al. Ischaemia–reperfusion injury to the intestine. Aust NZ J Surg 1998; 68: 554 – 561.pmid/9715130
6. Brady CA, Otto CM. Systemic inflammatory response syndrome, sepsis, and multiple organ dysfunction. Vet Clin North Am Small Anim Pract 2001; 31 (6): 1147 – 1162, v–vi.pmid/11727331
7. Olanders K, Zhengwu S, Borjesson A, et al. The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx and protease inhibitor levels in rats. Shock 2000; 18 (1): 86 – 92.
8. Liu XL, Nozari A, Basu S, et al. Neurologic outcome after experimental cardiopulmonary resuscitation: a result of delayed and potentially treatable neuronal injury. Acta Anaesthesiol Scand 2001; 46 (5): 537 – 546.pmid/11449557
9. Badylak SF, Lantz GC, Jeffries M. Treatment of reperfusion injury in dogs with surgically-induced gastric-dilatation-volvulus. Am J Vet Res 1992; 53: 1594 – 1598.pmid/1416361
10. Moore RM, Muir WW, Granger DN. Mechanisms of gastrointestinal ischemia–reperfusion injury and potential therapeutic interventions: a review and its implications in the horse. J Vet Intern Med 1995; 9 (3): 115 – 132.pmid/7674213
11. Cassutto BH, Misra HP, Pfeiffer CJ. Intestinal post ischemic reperfusion injury: studies with neonatal necrotizing enterocolitis. Acta Physiologica Hungarica 1989; 72 (1–3): 363 – 369.pmid/2765405
12. Leonard SE, Kirby R. The role of glutamate, calcium and magnesium in secondary brain injury. J Vet Emerg Crit Care 2002; 12 (10): 17 – 32.
13. Davis S, Helfaer MA, Traytsman RJ, et al. Parallel antioxidant and antiexcitotic therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke 1997; 28 (1): 198 – 204.pmid/8996512
14. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 2001; 298 (1): 249 – 256.pmid/11408549
15. Lantz GC, Badylak SF, Hiles MC, et al. Treatment of reperfusion injury in dogs with experimentally-induced gastric-dilatation-volvulus. Am J Vet Res 1992; 53: 1594 – 1598.pmid/1416361
16. 2+ exchange in myocardial reperfusion injury in open chest dogs: relative roles during ischemia and reperfusion. Cardiovasc Res 1997; 36 (3): 337 – 346.pmid/9534854
17. Segawa D, Sjoquist PO, Wang QD, et al. Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine. J Cardiovasc Pharmacol 2000; 36 (3): 338 – 343.pmid/10975591
18. Yamuda K, Matsui K, Satoh K, et al. Reduction of myocardial infarct size by SM-20550, a novel Na(+)/H(+) exchange inhibitor, in rabbits. Eur J Pharmacol 2000; 404 (1–2): 201 – 212.
19. 2+ exchange inhibitor, on myocardial ischemia/reperfusion injury. Nippon Yakurigaku Zassi 1998; 111 (2): 105 – 115.pmid/9558649
20. Horne MM, Pascoe PJ, Ducharme NG. Attempt to modify reperfusion injury of equine jejunal mucosa using dimethylsulfoxide, allopurinol and intraluminal oxygen. Vet Surg 1994; 23 (4): 241 – 249.pmid/8091626
21. Vatistas NJ, Snyder JR, Hildebrand SV, et al. Effects of U-74398G, a novel 21-aminosteroid, on small intestinal ischemia and reperfusion injury in horses. Am J Vet Res 1996; 57 (5): 762 – 770.pmid/8723896
22. Moore RM, Bertone AL, Bailey MQ, et al. Neutrophil accumulation in the large colon of horses during low-flow ischemia and reperfusion. Am J Vet Res 1994; 55 (10): 1454 – 1463.pmid/7998704
23. Cassutto BH, Pfeiffer CJ, Misra HP. Role of active oxygen species in hypothermia induced intestinal injury in weanling hamsters. Fed Proc 1987; (6): 2047.
24. Hoffmeyer MR, Scalia R, Ross CR, et al. PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia–reperfusion injury in mice. Am J Physiol Heart Circ Physiol 2000; 279 (6): H2824 – H2828.pmid/11087237
25. Ewer K. Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. Acta Paediatr Suppl 2002; 91 (437): 2 – 5.
26. Sun Z, Wang X, Deng X, et al. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats. Dig Surg 2000; 17 (1): 57 – 65.pmid/10720833
27. Loucks EB, Symersky P, Qayumi AK. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia–reperfusion injury. J Invest Surg 1997; 10 (6): 321 – 328.pmid/9654389
28. Hondeghem LC, Roden DM. Agents used in cardiac arrhythmias, In: Katzung BG. ed. Basic and Clinical Pharmacology. New York: Lange Medical Books/McGraw-Hill; 1998. pp. 232 – 233.
29. Plumb DC. Lidocaine HCl, In: Veterinary Drug Handbook, Pocket Edition. Ames: Iowa State Press; 2002. p. 504.
30. Adams HR Antiarrhythmic agents, In: Adams HR. ed. Veterinary Pharmacology and Therapeutics. Ames: Iowa State Press; 1995. pp. 358 – 371.
31. Alexander JH, Granger CB, Sadeowski Z, et al. Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb investigators. Am Heart J 1999; 137 (5): 799 – 805.pmid/10220627
32. Baraka A, Kawkabani N, Dabbous A, et al. Lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamping. J Cardiothorac Vasc Anesth 2000; 14 (5): 531 – 533.pmid/11052433
33. Garratt KN, Holmes DR, Moloina-Viamonte V, et al. Intravenous adenosine and lidocaine in patients with acute myocardial infarction. Am Heart J 1998; 136 (2): 196 – 204.pmid/9704679
34. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53 (1): 31 – 47.pmid/11744011
35. Hollman MW, Gross A, Jelacin N, et al. Local anesthetic effects on priming and activation of human neutrophils. Anesthesiology 2001; 95 (1): 113 – 122.
36. Arakawa K, Takahashi H, Nakagawa S, et al. The effects of lidocaine on superoxide production and p47 Phox translocation in opsonized zymosan-activated neutrophils. Anesth Analg 2001; 93 (6): 1501 – 1506.pmid/11726431
37. Gunyadin B, Demiryurek AT. Interaction of lidocaine with reactive oxygen and nitrogen species. Eur J Anaesthesiol 2001; 18 (12): 816 – 822.
38. Kirton OC, Civetta JM. Ischemia–reperfusion injury in the critically ill: a progenitor of multiple organ failure. Crit Care Med 1999; 7 (1): 87 – 95.
39. Kamiyam T, Tanonaka K, Harada H, et al. Mexiteline and lidocaine reduce post-ischemic and biochemical dysfunction of perfused hearts. Eur J Pharmacol 1995; 272 (2–3): 151 – 158.
40. + during myocardial ischemia: consequences for post-ischemic recovery. J Mol Cell Cardiol 1997; 29 (1): 85 – 96.pmid/9040024
41. Takeo S, Tanonaka K, Hayashi M, et al. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in post-ischemic contractile recovery of isolated, perfused hearts. J Pharmacol Exp Ther 1995; 273 (3): 1403 – 1409.pmid/7791114
42. Scheufler E, Mozes A, Guttman I, et al. R56865 is antifibrillatory in reperfused ischemic guinea pig hearts, even when given only during reperfusion. Cardiovasc Drugs Ther 1995; 9 (4): 545 – 553.pmid/8547204
43. Tosaki A, Balint S, Szekeres L. Protective effect of lidocaine against ischemia and reperfusion-induced arrhythmias and shifts of myocardial sodium, potassium, and calcium content. J Cardiovasc Pharmacol 1998; 12 (6): 621 – 628.
44. 2+ exchange inhibitor, on myocardial ischemia/reperfusion injury. Nippon Yakurigaku Zassi 1998; 111 (2): 105 – 115.pmid/9558649
45. 2+ concentration in gerbil hippocampal neurons. Anesthesiology 1997; 87 (6): 1470 – 1478.pmid/9416732
46. Terada H, Ohta S, Nishikawa T, et al. The effect of intravenous or subarachnoid lidocaine on glutamate accumulation during transient forebrain ischemia in rats. Anesth Analg 1999; 89 (4): 957 – 961.pmid/10512271
47. 2+ changes during in vitro ischemia in rat hippocampal slices: major roles for glutamate and Na+-dependent release from mitochondria. J Neurosci 1999; 19 (1): 3307 – 3315.pmid/10212290
48. Taylor CP, Burke SP, Weber ML. Hippocampal slices: glutamate overflow and cellular damage from ischemia are reduced by sodium-channel blockade. J Neurosci Meth 1995; 59 (1): 121 – 128.pmid/7475242
49. Lei B, Cotrell JE, Kass IS. Neuroprotective effect of low-dose lidocaine in a rat model of transient focal cerebral ischemia. Anesthesiology 2001; 95 (2): 445 – 451.pmid/11506119
50. Pfeiffer CJ, Keith JC, Cho CH, et al. Gastric and cardiac organoprotection by lidocaine. Acta Physiologica Hungarica 1989; 73 (2–3): 129 – 136.pmid/2596305
51. Pfeiffer CJ, Keith JC, April M. Topographic localization of gastric lesions and key role of plasma bicarbonate concentration in dogs with experimentally induced gastric dilatation. Am J Vet Res 1987; 48: 262 – 267.pmid/3103503
52. Das KC, Misra HP. Amelioration of postischemic reperfusion injury by antiarrhythmic drugs in isolated perfused rat lungs. Environ Health Perspect 1994; 102 (10): 117 – 121.pmid/7705285
53. Das KC, Misra HP. Antiarrhythmic agents- Scavengers of hydroxyl radicals and inhibitors of NADPH-dependent lipid peroxidation in bovine lung microsomes. J Biol Chem 1992; 267 (27): 19172 – 19178.pmid/1527038
54. Vitola JV, Forman MB, Holsinger JP, et al. Reduction of myocardial infarct size in rabbits and inhibition of activation of rabbit and human neutrophils by lidocaine. Am Heart J 1997; 133 (3): 315 – 322.pmid/9060800
55. Vitola JV, Forman MB, Holsinger JP, et al. Inhibition of neutrophil function by lidocaine as a mechanism for the beneficial effect to reduce myocardial reperfusion injury. J Am Coll Cardiol 1995; 25 (2, suppl 1): 102A – 103A.
56. Hatori N, Roberts RL, Tadokoro H, et al. Differences in infarct size with lidocaine as compared with bretylium tosylate in acute myocardial ischemia and reperfusion in pigs. J Cardiovasc Pharmacol 1991; 18 (4): 581 – 588.pmid/1724536
57. Hyvonnen PM, Kowolik MJ. Dose dependent suppression of the neutrophil respiratory burst by lidocaine. Acta Anaesthiol Scand 1998; 42 (5): 565 – 569.
58. Das KC, Misra HP. Impairment of raw 264.7 macrophage function by antiarrhythmic drugs. Mol Cell Biochem 1994; 132: 151 – 162.pmid/7969098
59. Lantos J, Roth E, Temes G. Effects of lidocaine on cerebral lipid peroxidation and neutrophil activation following complete compression ischemia. Arch Int Pharmacodyn Ther 1996; 331 (2): 179 – 188.pmid/8937628
60. Schmid RA, Yamashita M, Ando K, et al. Lidocaine reduces reperfusion injury and neutrophil migration in canine lung allografts. Ann Thoracic Surg 1996; 61 (3):949 – 955.pmid/8619724
61. Nishina K, Mikawa K, Takao Y, et al. Intravenous lidocaine attenuates acute lung injury induced by hydrochloric acid aspiration in rabbits. Anesthesiology 1998; 88 (5): 1300 – 1309.pmid/9605691
62. Ohsaka A, Saionji K, Sato N, et al. Local anesthetic lidocaine inhibits the effect of granulocyte colony stimulating factor on human neutrophil functions. Exp Hematol 1994; 22 (5): 460 – 466.pmid/7513653
63. Azuma Y, Shinohara M, Wang P, et al. Comparison of inhibitory effects of local anesthetics on immune functions of neutrophils. Int J Immunopharmacol 2000; 22 (10): 789 – 796.pmid/10963851
64. Schmidt W, Schmidt H, Bauer H, et al. Influence of lidocaine on endotoxin-induced leukocyte–endothelial cell adhesion and macromolecular leakage in vivo. Anesthesiology 1997; 87 (3): 617 – 624.pmid/9316968
65. Kiyonari Y, Nishina K, Mikawa K, et al. Lidocaine attenuates acute lung injury induced by a combination of phospholipase A2 and trypsin. Crit Care Med 2000; 28 (2): 484 – 489.pmid/10708188
66. Yan GT, Hao XH, Li ZJ. Tumor necrosis factor induced enhancement of neutrophil chemotaxis and adhesion through mediating of phospholipase A2 activation. Sheng Li Hsueh Poa 1995; 47 (6): 544 – 550.pmid/8762444
67. 2 activity correlates with postinjury multiple organ failure. Crit Care Med 2001; 29 (5): 989 – 993.pmid/11378609
68. Goldfien A. Adrenocorticosteroids and adrenocortical antagonists, In: Katzung BG. ed. Basic and Clinical Pharmacology. New York: Lange Medical Books/McGraw-Hill; 1998. p. 639.